Latest / "Isn't That Interesting?!": Breast Cancer Survivor Stories + Remarkable Research / Season 3 / Episode 3: Dr. Emanuela Grassilli
Transcript
- 0:00We all know that messaging has come a long way in social
- 0:03circles. Well, it's evolving rapidly in
- 0:05the science world, too. Researchers are working to
- 0:08decode the messages circulating in our bloodstream, opening the
- 0:12door to earlier detection of breast cancer and other
- 0:15diseases. In this episode of Isn't That
- 0:18Interesting, we speak with a Rome scientist using an
- 0:21earlier.org grant to advance this groundbreaking research.
- 0:25Here's our founder and executive director, Martha Kaley.
- 0:29I'm going to introduce you to one of our researchers, Dr.
- 0:33Emmanuel Grassili. Is that correct?
- 0:36Correct. Yes, correct.
- 0:37OK. She is an associate professor of
- 0:40general pathology at Blink Campus University in Rome.
- 0:44In 20/22, she received a research grant from earlier.org
- 0:49for improving liquid biopsy tools for earlier detection of
- 0:54breast cancer. Identification of extracellular
- 0:58vesicles, derived markers. And that's a lot of words to
- 1:02say, and I'm just going to let Doctor Casilli discuss what
- 1:07these extracellular vesicles are and what they it's like.
- 1:13I see it as it's a present from our bodies to to give us some
- 1:18information. So, so if you'll go ahead and
- 1:22talk about it, that'd be great. OK, so our cells usually
- 1:27communicate touching each others, but they also
- 1:30communicate on the long range just releasing some fragments,
- 1:35let's say of what is it is inside the the cytoplasm.
- 1:39They surrounded it with a membrane, they're membrane and
- 1:43then they just threw these this and this that is called extra
- 1:48vesticular molecule, sorry cellular vesicles and this
- 1:53vesicle can usually travel through the blood and reach also
- 1:58very wayside. And for example, they can
- 2:04contain molecules that are a message for cells that have left
- 2:10tumor and invaded tissue to form a metastasis.
- 2:14So these vesicles can be a way to communicate with a
- 2:18metastasis. But so mainly they have
- 2:23molecules from the tumor that are useful for the tumor itself.
- 2:27So it's not really a gift, but we can't take advantage of that
- 2:31if we can isolate them from the bladder of the patient and find
- 2:37markers. Actually, I'm just talking about
- 2:40the bad side of the stress cell or a vesicle.
- 2:42But there is also good side because this is a way that
- 2:45normal cells usually use to communicate.
- 2:49So it's not only a bad feature but also a good feature.
- 2:53Depends from which cells. If it is a normal cell or a
- 2:57tumorous cell, it release the the content.
- 3:01But lucky for us they are rich of different molecules, protein,
- 3:06RNA, pieces of DNA. There is a lot of stuff inside.
- 3:10So the project and they are studying these vesicles in
- 3:16several type of cancer right now.
- 3:18But the purpose of this project that you very thankfully granted
- 3:24us was to find the new early markers.
- 3:28Because the fact is that not all the women are willing to do all
- 3:34the, let's say, mammogram, mammograms or eventually they
- 3:38cannot afford them. Because in Italy, we are the
- 3:42initial system that just give the mammogram for free to all
- 3:48the women above 50. But I know that in the States,
- 3:51you have to pay to get these and they are very costly.
- 3:56And if we can find something that is easier like just a
- 4:01simple blood test, maybe it would increase the number of
- 4:05women that can afford that are willing to get tested.
- 4:11So we started using the blood from patients because we want to
- 4:18to see if there is something different in the bladder of the
- 4:21patients compared to the normal woman.
- 4:24And I was very surprised because it took us some time to enroll
- 4:28the patients. I was expecting that it would be
- 4:32much easier to convince them to give us some blood when we were
- 4:36going to a regular follow up meeting with the with the
- 4:40oncologist. But it was pretty harder to to
- 4:44to find 30 woman because that was the size of the sample, 30
- 4:49woman with cancer, breast cancer and 30 normal subject.
- 4:53And so we started isolated these vesicles because there are
- 4:59methods to isolate the vesicles from the blood and we use very
- 5:03sophisticated tests to recognize all the proteins that were
- 5:08inside these vesicles can. I ask you a question.
- 5:13How long? How long have you known those
- 5:16particular proteins or markers or what what led you to choosing
- 5:22those markers? Are there other markers?
- 5:26OK. So we compared the results of
- 5:30the identification of all the proteins in the normal vesicle
- 5:33and in the tumoral vesicle. And there were of course we have
- 5:38to to decide which is a good difference because it's not on
- 5:44off sometimes is this protein is present in a small amount and
- 5:49this protein is present in a very large amount.
- 5:51So we have to to to fix what we call cut off.
- 5:57And so we compared all these molecules and we found four of
- 6:01them that if taken together are really a really streaking and
- 6:07very significant from the statistical point of view
- 6:10difference between normal and samples.
- 6:15So we are really puzzled because these are known proteins, never
- 6:22been involved in breast cancer so far.
- 6:25So it's pretty difficult to understand that which is the
- 6:28role of these proteins. But what is right really
- 6:31striking is that they really identify patients from normal
- 6:37donors. So next step, and this is what
- 6:42we have done so far with the grant.
- 6:45We are just now writing the paper to publish our results.
- 6:49But of course we are all already planning what to do next and
- 6:54what to do next would be to and I know this is going to be
- 6:58difficult since we have we have difficulties in people in take
- 7:03having the sample of blood from the woman that were already
- 7:06sick. Now we would like to with help
- 7:10very, very precious health of our oncologist in the hospital
- 7:13to try to enroll normal let's say women that are going
- 7:20undergoing the regular mammogram each each two year because here
- 7:25the rule is above 50 each two year and 70.
- 7:28Our system, national system will pay you the mammogram.
- 7:31So we would like to go to convince this woman that are
- 7:36just doing a regular check up to give us blood in blind.
- 7:42And after that examine, of course we need a lot of patients
- 7:48because they let's say one woman in eight that is 13% get breast
- 7:54cancer. So we need at least 100
- 7:58volunteer to give us blood to be able to see if just screening
- 8:04this molecule, the level of this molecule in the blood, we can
- 8:08identify potential the patients NCN not knowing nothing from the
- 8:16mammogram. Of course we have to double
- 8:18check with the mammogram if our set up was able our let's say
- 8:25analysis of this markers that would identify the patients.
- 8:30So, so essentially our, the grant that we awarded you was
- 8:36helped you with the the original essentially the proof of
- 8:40concept, right? So it helped you with that and
- 8:44then your results will be able from from our grant, then the
- 8:49results will be able for you to apply for larger funding.
- 8:53Is that correct? Yeah.
- 8:55I mean it wasn't the proof of concept, it was the
- 8:58identification of potential markers.
- 9:01Now the proof of proof of concept will be to investigate
- 9:05in to investigate the level of these markers in women that are
- 9:09undergoing A mammogram and then see if our results match with
- 9:14the one of the mammogram or even or even better if the mammogram
- 9:19say everything is good, but the bladder analysis will say we're
- 9:26not so sure, just push the patients to the potential
- 9:31patient to go to undergo further analysis.
- 9:35So. This will be the proof of
- 9:38concept to see if the our four proteins taken together could
- 9:43have the same results of the mammogram or even better to
- 9:47detect even earlier tumor abreast tumor.
- 9:50So that would be the proof of concept.
- 9:52Oh, good. OK.
- 9:53So how do you see AI playing significant role here?
- 9:57I feel like that that would help us.
- 9:59I mean, maybe I didn't get the meaning.
- 10:02Can you rephrase it? Artificial intelligence using
- 10:06that tool, will that be able to give you more different
- 10:10readings? Artificial intelligence may be
- 10:15applied to the part of the mammograms because the
- 10:18artificial artificial intelligence is now being
- 10:22developed in such a way that the educator, the machine is
- 10:26educated to recognize what the human eye can yet see on the
- 10:32mammogram. So in that case artificial
- 10:35intelligence is being proved in several settings to be really be
- 10:40able to get as more lesion that the eye or the radiologist
- 10:45cannot see. But in our case we have to test
- 10:50the blood for the protein. There is no other way than
- 10:53testing the blood, right? Right.
- 11:00OK. I read that that I guess the
- 11:01goal of this like testing it through blood, also saliva and
- 11:07urine, but it's harder to get those results because of the
- 11:13need for volume. Is that correct?
- 11:16I know that there are settings in which the saliva and the
- 11:20urine have been used, but it depends from the tumor.
- 11:22Let's say that if you have a mouth of forced respiratory
- 11:27waste tumor, you can get differences in the saliva not
- 11:32only on the extracellular vesicle but also on the
- 11:35bacteria. And I could expect that in the
- 11:39urine you could find the vesicles coming from tumors of
- 11:43the kidney or the bladder or things like this.
- 11:49I don't. I don't expect messages from the
- 11:51breast tumor to this size, but you never know.
- 11:55So. So the chances are it's always
- 11:58better to do the liquid biopsy, right?
- 12:01With blood, yeah. Yeah, It, it, the liquid biopsy
- 12:06is the most promising way to get informations about tumors that
- 12:12are not giving yet. They're not saying hello, Amir,
- 12:16let's say. Right.
- 12:18So when you, when you do, when you get all you get your paper
- 12:22written and then you enroll people for the the testing.
- 12:28So what is your goal after that? What do you do after that?
- 12:35Of course, if testing will be giving the results, which we
- 12:40hope for, it's going to take some time because I also have to
- 12:45find the money for that because it's very difficult to get money
- 12:48for research in Italy and you have to write 20 projects before
- 12:53you get funded one usually. So it's going to take some time
- 12:58to to get to go there. But after that, the thing that I
- 13:04could expect is to develop a test, a rapid test that is can
- 13:09be used that is going to be FDA approved and also be part of the
- 13:15of the project. Take some some time because you
- 13:18have to do all the tests, you have to develop and prove the
- 13:22test that is right for the market.
- 13:25It's something different from what we use in research.
- 13:29And so there are a lot of let's say norms that regulates the
- 13:35field and you have to comply with all these and give these
- 13:39results to the FDA before you get the approval.
- 13:42So from the moment we can prove that it really this set of four
- 13:48protein really discriminates between normal tumor patients
- 13:52and that is a very early test that you can apply from that
- 13:59moment to the moment that the test start to the FDA and the
- 14:04clear procedure can be a few years so.
- 14:10Let's let's make it short. Let's get this going.
- 14:13So I really hope that all of this will will just be quickly
- 14:17resolved for us all. Thank you for, for approaching
- 14:22this work. It sounds like it's so positive
- 14:25and it's very encouraging. So I, I really appreciate your
- 14:30sharing with us the, the, the understanding of the science and
- 14:36thank you for doing that. So.
- 14:39I hope I've been simple enough and that it can be understood
- 14:43even without being a scientist. Well, yes, and I think that is
- 14:48true because you have shared that there's so much promise out
- 14:53there. It doesn't.
- 14:54You don't have to understand all of the detail of the science
- 14:58that when you know that the scientist is confirmed about
- 15:03what they're doing and, and has been able to demonstrate some of
- 15:07that. So I think that that's the
- 15:09really encouraging part about it.
- 15:11So I, I really appreciate your spending your time with us and,
- 15:16and helping us understand. And just so you know is I have
- 15:20friends who are oncologists and they listen to our podcasts.
- 15:25So they'll be very interested in listening to this.
- 15:28They listen and discuss it in their clinics.
- 15:32It should be very exciting for them.
- 15:34I hope so. And if you let me, I would also
- 15:38thanks. My copy I because since I was
- 15:42moving to Rome, I asked to have a copy I that is still in the
- 15:47University of Milano. My copy I is a Professor Marie
- 15:49Gracerito and I wouldn't have been able to do anything if she
- 15:54wasn't helping a lot. So I would like to thanks.
- 16:00Thank you. That is great.
- 16:02Well, thank you so much and we'll we'll listen up for
- 16:05whenever you you go through this and succeed.
- 16:09I know it's going to happen. So thank you so much.
- 16:13OK. Thank you to you and for all the
- 16:16opportunities your foundation gave us.
- 16:18Thank you. OK, thanks.
- 16:20Bye. Bye.
- 16:20Bye. This episode of Isn't That
- 16:23Interesting was made possible thanks to volunteers and donors
- 16:26just like you. It was hosted by Martha Kaley,
- 16:29founderofearlier.org and edited by Liam Mcburney.
- 16:33I'm Valerie Amsterdam, reminding you that for the last 30 years,
- 16:37this is North Carolina based organization has helped fund
- 16:40groundbreaking research all over the world, from molecular
- 16:44imaging to a sensitive blood test for breast cancer.
- 16:48Plain and simple, earlier detection saves lives.
- 16:50And you can help host a fundraising event.
- 16:53Make a donation for Volunteer Your Time.
- 16:56You can find us not only on the web but on Facebook and
- 16:59Instagram too. Let's change the picture of
- 17:01breast cancer together.